Bullous pemphigoid (BP) is a rare autoimmune skin blistering disease, characterized by the
presence of autoantibodies against hemidesmosomal autoantigens. Cytokine expression is …

Background Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease
characterized by tissue-bound and circulating autoantibodies directed against BP180 and/or …

Background: DNA extracellular traps (ETs), released by neutrophils (NETs), or eosinophils
(EETs), play a pathogenic role in several autoimmune disorders. However, to date, NETs …

Background and objectives The features of bullous pemphigoid (BP) patients presenting
with mucosal lesions are not established. We aimed to elucidate the clinical and …

Pemphigus is a life‐threatening autoimmune blistering disease. Patient characteristics,
treatment courses, and outcomes remain unclear owing to its rarity. To describe the …

Bullous pemphigoid (BP) is an autoimmune blistering disease which carries a significant
mortality and morbidity. While historically BP has been characterized as an IgG driven …

Incidence of bullous pemphigoid (BP), the main pemphigoid disease, has increased over
the past decades. Despite growing insights into pathogenic mechanisms, treatment is still …

Pemphigus vulgaris (PV) is a potentially fatal autoimmune blistering disease characterised
by cell‐cell detachment or acantholysis. The mechanisms which follow antibody (Ab) …

Background: Pemphigus is a chronic auto-immune blistering disease with four main
variants, ie pemphigus vulgaris (PV), foliaceus (PF), erythematosus (PE) and vegetans. The …

Bullous pemphigoid (BP) is an autoimmune blistering disease characterized by
autoantibodies targeting cellular adhesion molecules. While IgE autoantibodies are …